IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
36.74
+0.45 (1.24%)
At close: Jun 26, 2026, 4:00 PM EDT
36.00
-0.74 (-2.01%)
After-hours: Jun 26, 2026, 6:30 PM EDT
IDEAYA Biosciences Employees
IDEAYA Biosciences had 145 employees as of December 31, 2025. The number of employees increased by 14 or 10.69% compared to the previous year.
Employees
145
Change (1Y)
14
Growth (1Y)
10.69%
Revenue / Employee
$1,553,586
Profits / Employee
-$965,924
Market Cap
3.49B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Beam Therapeutics | 522 |
| Arcutis Biotherapeutics | 354 |
| Vera Therapeutics | 339 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Alumis | 227 |
| uniQure | 221 |
IDYA News
- 2 days ago - IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 11 days ago - Ideaya Biosciences elects CEO Yujiro Hata as chairman - TheFly
- 11 days ago - IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors - PRNewsWire
- 13 days ago - Ideaya Biosciences enrolls first patient in IDE892 trial - TheFly
- 13 days ago - IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers - PRNewsWire
- 17 days ago - IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 19 days ago - Ideaya Biosciences 5.56M share Spot Secondary priced at $27.00 - TheFly
- 19 days ago - IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants - PRNewsWire